We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Bring photo ID to vote Check what photo ID you'll need to vote in person in the General Election on 4 July.
The Minister of State at DHSC has responded to recommendations made by the Regulatory Horizons Council (RHC) on the regulation of medical devices.
The establishment of a regulatory framework for POC manufacturing would bring a range of benefits to patients, healthcare professionals and innovators.
The Medicines and Healthcare products Regulatory Agency (MHRA) has confirmed that UL International UK Ltd is now designated to assess most in-vitro diagnostic (IVD) devices, increasing the UK’s capacity to process conformity assessments and ensure safe and effective IVDs reach the UK public
Horizon Scanning in the MHRA Innovation Accelerator includes a focus on the identification of Actionable Horizon Scanning Signals, but what are these, and how and why do we identify them?
Professor Tom Clutton-Brock MBE has been appointed as Chair of the Medicines and Healthcare products Regulatory Agency’s (MHRA) Interim Devices Working Group
This new vaccine, VidPrevtyn Beta, has been authorised after meeting the MHRA’s required safety, quality and effectiveness standards.
The Medicines and Healthcare products Regulatory Agency (MHRA) has received a total of £970,688 from BEIS’ Regulators’ Pioneer Fund for three projects that aim to unlock cutting edge regulatory innovation, to drive real world benefits for patients, the healthcare sector and clinical research…
Life Sciences Council Joint Statement on a new agreement to accelerate the delivery of the future UK HealthTech regulatory system.
Horizon scanning at the Medicines and Healthcare products Regulatory Agency (MHRA), and collaboration with other medical device regulators, leads to the development of guiding principles that can help inform the development of Good Machine Learning Practice.
The Comirnaty COVID vaccine has met the MHRA’s required safety, quality and effectiveness standards to be authorised for use in this age group
Report from the Advisory Council on the Misuse of Drugs (ACMD) on the classification and schedule of Remimazolam.
Twenty four innovative projects awarded up to £12 million to remove regulatory barriers and support businesses brings products and services to market.
Patients will benefit from cutting-edge new treatments as the government introduces a Vaccine Taskforce style approach to tackling health challenges.
Patients, carers and healthcare professionals with kits of the opioid overdose medicine Prenoxad Injection must visually check for the presence of two needles inside their kit. Any kits that do not have two needles should be…
This adapted COVID-19 vaccine targets both the original virus and the Omicron BA.4 and BA.5 sub-variants.
To improve medical product safety for all, report suspected side effects and adverse incidents as part of the #MedSafetyWeek global campaign
Patients using antibiotic Targocid 200mg powder at home must check if the batch number of their medicine is 0J25D1 or 0J25D2. Anyone who has one of these two batches should stop their treatment and seek immediate medical adv…
Significant funding for research centres across the country to support the improved delivery of health and care services and ground-breaking new treatments.
Healthcare professionals asked to share their views on how they want to receive safety information from the UK medicines and medical devices regulator
The Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have been awarded £1.8m funding by Wellcome over three years to explore and produce guidance on regulating digital mental health tools.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).